Lyell Immunopharma, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of LYEL for the last quarter is 3.00 k USD, and it's 76.92% lower compared to the previous quarter. The net income of Q1 24 is -60.67 M USD.